Eupraxia Pharmaceuticals (TSE:EPRX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Eupraxia Pharmaceuticals Inc. has released its consolidated financial statements for the first half of 2024, revealing an increase in total assets to $24.9 million from $20.2 million at the end of the previous year. The company’s liabilities have also decreased to $11.6 million from $19.3 million, with the shareholders’ equity showing a significant uptick from $892,326 to $13.3 million over the same period.
For further insights into TSE:EPRX stock, check out TipRanks’ Stock Analysis page.
